Istituto Clinico Humanitas

Hospital


Location: Mailand (Milano), Italy (IT) IT

ISNI: 0000000417568807

ROR: https://ror.org/05d538656

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Mapping and predicting mortality from systemic sclerosis (2017) Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, et al. Journal article Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal L (2017) Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, La Rosee P, Binder M, et al. Journal article Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart (2017) Perrino C, Barabasi AL, Condorelli G, Davidson SM, De Windt L, Dimmeler S, Engel F, et al. Journal article Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease (2016) Stitziel NO, Stirrups KE, Masca NGD, Erdmann J, Ferrario PG, Koenig IR, Weeke PE, et al. Journal article Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response? (2016) Genua M, Becker C, Vetrano S Journal article The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis (2016) Lopez Posadas R, Becker C, Günther C, Tenzer S, Amann KU, Billmeier U, Atreya R, et al. Journal article Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas (2016) Ronchi CL, Peverelli E, Herterich S, Weigand I, Mantovani G, Schwarzmayr T, Sbiera S, et al. Journal article Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial (2016) Ferreri AJM, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, et al. Journal article Programming of Intestinal Epithelial Differentiation by IL-33 Derived from Pericryptal Fibroblasts in Response to Systemic Infection (2016) Mahapatro M, Försch S, Hefele M, He GW, Giner-Ventura E, Mchedlidze T, Kindermann M, et al. Journal article Consensus nomenclature for CD8(+) T cell phenotypes in cancer (2015) Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, et al. Journal article